-The Hindu Business Line Public procurement at a negotiated price is a better option. Price curbs deter producers and don’t check pharmacy margins The Government’s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive? First came the move to extend the scope...

-The Hindu Business Line Come November, the Jan Aushadhi initiative completes nine years. But despite its recent achievements, there's more work to be done. PT Jyothi Datta writes Earlier this year, Chemicals and Fertilizers Minister Ananth Kumar vowed to end the “medicine mafia” in the country by opening many more Jan Aushadhi kendras, stores that sell generic medicines at affordable prices. Kumar was echoing the mission outlined by Finance Minister Arun Jaitley...

-The Hindu Business Line The global pulse trade is in a tailspin. After living in a comfort zone provided by India in the form of a large ready market for long years, pulse exporting nations — many of them cultivating the leguminous crop with India as the primary target market — are now forced to grapple with new ground realities. To be sure, not only has India, the world’s largest producer, processor,...

-The Hindu Business Line The dilution of government intervention in the form of minimum support prices, procurement and public distribution is undermining agricultural production in the country Farmer movements and farm loan waivers in different States have driven home the fact that the viability of agriculture is under challenge. This is surprising, since the comprehensive framework for reviving agricultural production, introduced in response to the agricultural crisis in mid-1960s, is in principle...

-Livemint.com Govt plans to?help firms revamp manufacturing units,?refurbish machinery,?ensure subsidized power in bid to produce drugs such as penicillin at competitive rates New Delhi: The Department of Pharmaceuticals (DoP), during a meeting on Wednesday, urged pharma companies to strive for self-sufficiency in critical drugs like penicillin, rifampicin and insulin, in a sign of government concern over India’s dependence on Chinese imports. A large number of so-called active pharmaceutical ingredients (APIs), or bulk drugs,...